CannaPowder, Inc.

CannaPowder, Inc. (OTC:CAPD)
OTC Ticker Symbol:

CannaPowder, Inc. (OTC:CAPD), through its newly-organized Israeli subsidiary, Canna Powder Ltd,ย entered into Agreements with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, located in Jerusalem, Israel, for production of powders from cannabinoid oil for the treatment of a variety of medical conditions.ย CannaPowder agreed to fund a study entitled Powder Formulation of Cannabinoid Oil and Yissum granted the Company an option for an exclusive worldwide license (subject to a definitive License Agreement), to commercially exploit the production of Cannabis Powder Medical Products. The Company successfully completed an equity raise of in excess of $1 million to fund the Study and the development and production of its Cannabis Powder Medical Products.

ZIP Code:
Business Website Address:
Business Phone Number: